Where momentum stalls

05 FRICTION POINTS

​

​​​​​You didn't spend years building breakthrough technology to get stuck in endless pilots.

 

You solved a meaningful clinical problem.

​

You generated evidence. Earned the confidence of clinicians. Built a product that people genuinely believe can improve care.

​

So why isn't adoption following?

 

Because in healthcare, clinical validation is only the beginning.

​

The biggest barrier to growth isn't proving your solution works. It's helping health systems, payers, and enterprise buyers change the way they work.

​

This is where even exceptional companies lose momentum.

​

Where growth breaks down

​

Your clinical champion can't buy your solution.

The physician who believes in your innovation isn't the one responsible for budgets, operations, IT, procurement, or reimbursement.

Your pilot proves the product. It doesn't prove the business case.

Strong clinical results don't automatically translate into organizational commitment or enterprise-wide adoption.

​

Every stakeholder is asking a different question.

Clinical impact. Financial return. Operational risk. Workflow disruption. Cybersecurity. Reimbursement. If those answers aren't connected into one compelling story, decisions stall.

​

No one is saying no. They're just not saying yes.

Months pass in committee reviews, competing priorities, and internal alignment while momentum quietly fades.

​

Every deal feels like reinventing the wheel.

Without a repeatable commercialization strategy, each opportunity starts from scratch, making growth difficult to predict and even harder to scale.

 

 

The companies that break through don't just build better technology.

They make adoption easier.

That's the difference between an innovation that earns admiration and one that becomes part of everyday care. Our role is to help founders bridge that gap: translating clinical innovation into a commercial strategy that resonates with every stakeholder involved in the buying decision, so momentum turns into adoption, and adoption turns into sustainable growth.

 

We've sat on the other side of this table.

Our team brings over 50 years of combined commercial leadership across GE Healthcare, Edwards Lifesciences, IQVIA, Philips, and Eli Lilly, inside the same health systems, payer organizations, and physician groups your buyers report to.

​

COMBINED ACADEMIC

MBA Biology Psychology Computer Engineering Masters in Education

​

LEADERSHIP

Kellogg Executive CMO ProgramTeach for AmericaCertified CoachGE Healthcare Leadership Training